Meryem AKTAN, Eray KARAHACİOGLU, Hatice ONDER, Gul KANYİLMAZ

Prognostic factors for survival in adult patients with grade II glial tumors

Aim: To investigate survival results of patients with low grade gliomas (LGGs) and to evaluate the predictive role of clinico-pathologic prognostic factors on survival.Material and Methods: Between 2003 and 2014, the adult patients with Grade II glial tumors were evaluated retrospectively. Several variables were investigated to find prognostic factors related with the overall survival (OS) and progression-free survival (PFS).Results: This study involved in 124 patients with median 40 (range; 6-132) months follow up. The average OS for the all patients was 7.8 years. 2-, 5- and 10- year OS ratios were 91%, 73% and 55%, respectively. Patients with low pignatti risk score had a longer OS than high pignatti risk score (p=0.01). Patients with seizure had a better OS (p=0.03). Patients with biopsy/partial resection had apoorer OS (p=0.02). Patients with residue after initial surgery had a worse OS (p=0.03). If the patients had recurrence or progression, the patients had poorer OS (p=0.01). Tumor with malignant transformation (p=0.01) and glioblastoma subtype after second surgery (p=0.003) had a poorer OS. The Pignatti risk score and seizure were the independent prognostic factors for PFS.Conclusion: The extent of surgery and recurrence or progression of Grade II glioma were the independent prognostic factors for OS. The Pignatti risk score and seizure were the independent prognostic factors for PFS.

PDF

___

Majchrzak K, Kaspera W, Bobek-Billewicz B, Hebda A, Stasik-Pres G, Majchrzak H, et al. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study. Clin Neurol Neurosurg 2012;114 (8):1135-44.
Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006;106(6):1358-63.
Hanzely Z, Polgar C, Fodor J, Brucher JM, Vitanovics D, Mangel LC, et al. Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: long term results of 97 patients. J Neurooncol 2003;63(3):305-12.
Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996;36(3):549-56.
Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: An interim analysis. Int J Radiat Oncol Biol Phys 2002.52:316-24.
Rudoler S, Corn BW, Werner-Wasik M, Flanders A, Preston PE, Tupchong L, et al. Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/ magnetic resonance imaging era. Am J Clin Oncol 1998;21(1):23-7.
van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults. The EORTC 22845 randomised trial. Lancet 2005;366(9490):985-90.
Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 2011;29(23):3163-72.
Novais EN, Demiralp B, Alderete J, Larson MC, Rose PS, Sim FH. Do Surgical Margin and Local Recurrence Influence Survival in Soft Tissue Sarcomas? Clin Orthop Relat Res 2010;468(11):3003-11.
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for breast cancer on local recurrence and 15-year survival: An overview of randomised trials. Lancet 2005;366(9503):2087-106.
Sanai N, Berger MS. Recent surgical management of gliomas. Adv Exp Med Biol 2012;746:12-25.
Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008;26(8):1338-45.
Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg 2013;118(6):1157-68.
Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, et al. Preoperative prognostic classification system for hemispheric low grade gliomas in adults. J Neurosurg 2008;109(5):817-24.
Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, et al. Guidelines on management of low grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 2010;17(9):1124-33.
Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001;95(5):735-45.
Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, et al. Supratentorial low grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 1997;15(4):1294-301.
Mariş D, Nica D, Mohan D, Moisa H, Ciurea AV. Multidisciplinary management of adult low grade gliomas. Chirurgia (Bucur) 2014;109(5):590-9.
Mariş D, Nica D, Mohan D, Moisa H, Ciurea AV. Multidisciplinary management of adult low grade gliomas. Chirurgia (Bucur) 2014;109(5):590-9.
Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusll RM, et al. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 2011;81(1):218-24.
Jung TY, Jung S, Moon JH, Kim IY, Moon KS, Jang WY. Early prognostic factors related to progression and malignant transformation of low-grade gliomas. Clin Neurol Neurosurg 2011;11389):752-7.
Shields LB, Choucair AK. Management of Low-Grade Gliomas: A Review of Patient-Perceived Quality of Life and Neurocognitive Outcome. World Neurosurg 2014;82(1- 2):299-309.
Janny P, Cure H, Mohr M, Heldt N, Kwiatkowski F, Lemaire JJ, et al. Low grade supratentorial astrocytomas. Management and prognostic factors. Cancer 1994;73(7):1937-45.
Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:(8)2076-84.
2 Pouratian N, Schiff D. Management of Low-Grade Glioma. Curr Neurol Neurosci Rep 2010;10(3):224-31.
Shaw E, Arusell R, Scheithauer B, O’Fallon J, O’Neill B, Dinapoli R, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/ Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20(9):2267-76.